Sphingosine kinase 2 and multiple myeloma

Research output: Contribution to journalArticle

2 Citations (Scopus)
23 Downloads (Pure)

Abstract

News on: Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress, by Wallington-Beddoe et al. Oncotarget. 2017; doi: 10.18632/oncotarget.17115.
Original languageEnglish
Article number17420
Pages (from-to)43596-43597
Number of pages2
JournalOncotarget
Volume8
Issue number24
DOIs
Publication statusPublished - 25 Apr 2017

Keywords

  • Sphingosine kinase 2
  • multiple myeloma
  • MM
  • chemotherapeutic agents
  • bortezomib

Cite this